Protagenic Therapeutics- Warrants (13/04/2025) Return on Equity

The latest ROE for PTIXW is 316.93%. That is above the Industrials sector average of 20.55%. Investors often review this figure alongside Protagenic Therapeutics- Warrants (13/04/2025)'s historical trend and sector peers before judging valuation or financial health.

Against Industrials companies, PTIXW currently prints 316.93% for ROE, while the sector average sits near 20.55%. That is roughly 1442.5% above the sector mean. Large gaps often invite a closer look at Protagenic Therapeutics- Warrants (13/04/2025)'s growth, margins, and balance sheet.

Return on Equity shows how effectively Protagenic Therapeutics- Warrants (13/04/2025) converts resources into returns. At 316.93%, PTIXW may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PTIXW's ROE (316.93%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Protagenic Therapeutics- Warrants (13/04/2025)'s ROE against similar Industrials names. You can also browse sector and industry screens on Stockcircle for a broader set of Industrials companies and their key multiples and fundamentals.